ADUS

$101.52

Market ClosedAs of Mar 17, 8:00 PM UTC

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$101.52
Potential Upside
2.1%
Whystock Fair Value$103.70
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company op...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.88B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.45
Beta
Defensive asset. Lower volatility than the S&P 500.
0.93
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
9.33%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.63

Recent News

MarketBeat
Mar 17, 2026

Addus HomeCare Details 2026 Priorities as Medicaid Redeterminations Ease at KeyBanc Forum

Addus HomeCare (NASDAQ:ADUS) executives used a fireside chat at KeyBanc’s Healthcare Forum to outline operational priorities for 2026, discuss the pace of personal care census recovery after Medicaid redeterminations, and address the policy backdrop around Medicaid funding and oversight. 2025 focus

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts

An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 16, 2026

Addus HomeCare Says Q4 Ended Strong, Sees Solid Q1 Start Despite Weather, Holiday Disruptions

Addus HomeCare (NASDAQ:ADUS) executives said the company exited the fourth quarter in “really good shape,” citing a strong earnings quarter and what they described as a solid start to the first quarter, despite typical holiday-season scheduling pressures and weather-related disruptions early in the

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

Q4 Earnings Roundup: Addus HomeCare (NASDAQ:ADUS) And The Rest Of The Senior Health, Home Health & Hospice Segment

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Addus HomeCare (NASDAQ:ADUS) and the best and worst performers in the senior health, home health & hospice industry.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 3, 2026

Addus HomeCare CFO Flags Medicaid Rate Outlook, Gentiva Deal Progress, and M&A Pipeline at Conference

Addus HomeCare (NASDAQ:ADUS) CFO Brian Poff discussed the company’s strategy, Medicaid rate environment, compliance posture, and recent operating trends in a wide-ranging conversation that also touched on M&A priorities and growth initiatives in personal care and hospice. From a pure-play perso

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.